ArticleHepatic medicine : evidence and research2017
Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy.
Daniela Paola Roggeri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.